Tor Magnus Smedman

  • Consultant; MD

Education and work experience

  • 2022 –present date: Attending Oncologist, Gastrointestinal Oncology group, Dept. of Oncology, Oslo University Hospital, Norway
  • 2020-2022: Attending Oncologist, Malignant Melanoma group, Dept. of Oncology, Oslo University Hospital, Norway
  • 2017-present date: PhD student, University of Oslo, Norway
  • 2012-2019 : Residency Clinical Oncology, Oslo University Hospital, Norway
  • 2008-2012: Residency internal medicine, Akershus University Hospital, Norway
  • 2007-2008: General physician internship, Porsgrunn, Norway
  • 2006-2007: Internal medicine/surgery internship, Telemark Hospital, Norway
  • 2005: Cand. Med, Szeged University, Hungary
 

Publications 2021

Dueland S, Smedman TM, Røsok B, Grut H, Syversveen T, Jørgensen LH, Line PD (2021)
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Transpl Int, 34 (11), 2205-2213
DOI 10.1111/tri.13995, PubMed 34792825

Publications 2020

Smedman TM, Line PD, Hagness M, Syversveen T, Grut H, Dueland S (2020)
Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)
BJS Open, 4 (3), 467-477
DOI 10.1002/bjs5.50278, PubMed 32333527

Publications 2019

Smedman TM, Guren TK, Line PD, Dueland S (2019)
Transplant oncology: assessment of response and tolerance to systemic chemotherapy for metastatic colorectal cancer after liver transplantation - a retrospective study
Transpl Int, 32 (11), 1144-1150
DOI 10.1111/tri.13471, PubMed 31209941

Publications 2018

Smedman TM, Line PD, Guren TK, Dueland S (2018)
Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients
Acta Oncol, 57 (10), 1414-1418
DOI 10.1080/0284186X.2018.1479069, PubMed 29912605

Page visits: 59